A new trading day began on Tuesday, with Aptevo Therapeutics Inc (NASDAQ: APVO) stock price remained unchanged from the previous day of trading, before settling in for the closing price of $0.34. APVO’s price has ranged from $0.33 to $33.67 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 2.12% over the past five years. Meanwhile, its annual earnings per share averaged 81.87%. With a float of $6.03 million, this company’s outstanding shares have now reached $6.26 million.
Let’s look at the performance matrix of the company that is accounted for 42 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Aptevo Therapeutics Inc (APVO) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Aptevo Therapeutics Inc is 3.61%, while institutional ownership is 10.38%.
Aptevo Therapeutics Inc (APVO) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -4.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 81.87% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.40% during the next five years compared to 80.96% growth over the previous five years of trading.
Aptevo Therapeutics Inc (NASDAQ: APVO) Trading Performance Indicators
Here are Aptevo Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.72.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -452.26, a number that is poised to hit -4.21 in the next quarter and is forecasted to reach -14.49 in one year’s time.
Technical Analysis of Aptevo Therapeutics Inc (APVO)
Aptevo Therapeutics Inc (NASDAQ: APVO) saw its 5-day average volume 0.83 million, a negative change from its year-to-date volume of 2.11 million. As of the previous 9 days, the stock’s Stochastic %D was 3.82%. Additionally, its Average True Range was 0.15.
During the past 100 days, Aptevo Therapeutics Inc’s (APVO) raw stochastic average was set at 0.23%, which indicates a significant decrease from 2.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.33% in the past 14 days, which was lower than the 151.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3839, while its 200-day Moving Average is $6.6047. Nevertheless, the first resistance level for the watch stands at $0.3476 in the near term. At $0.3552, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.3649. If the price goes on to break the first support level at $0.3303, it is likely to go to the next support level at $0.3206. Assuming the price breaks the second support level, the third support level stands at $0.3130.
Aptevo Therapeutics Inc (NASDAQ: APVO) Key Stats
With a market capitalization of 2.13 million, the company has a total of 6,260K Shares Outstanding. Currently, annual sales are 0 K while annual income is -24,130 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,310 K.
